Mats Jerkeman

Mats Jerkeman

UNVERIFIED PROFILE

Are you Mats Jerkeman?   Register this Author

Register author
Mats Jerkeman

Mats Jerkeman

Publications by authors named "Mats Jerkeman"

Are you Mats Jerkeman?   Register this Author

91Publications

1919Reads

20Profile Views

Comorbidities and sex differences in causes of death among mantle cell lymphoma patients - A nationwide population-based cohort study.

Br J Haematol 2019 Nov 13. Epub 2019 Nov 13.

Department of Medicine, Division of Clinical Epidemiology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16317DOI Listing
November 2019

Body composition measurements and risk of hematological malignancies: A population-based cohort study during 20 years of follow-up.

PLoS One 2018 23;13(8):e0202651. Epub 2018 Aug 23.

Center for Hematology and Regenerative Medicine, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0202651PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107196PMC
February 2019

Optimizing Outcome Prediction in Diffuse Large B-Cell Lymphoma by Use of Machine Learning and Nationwide Lymphoma Registries: A Nordic Lymphoma Group Study.

JCO Clin Cancer Inform 2018 12;2:1-13

Jorne L. Biccler, Lasse Hjort Jakobsen, Martin Bøgsted, and Tarec C. El-Galaly, Aalborg University Hospital and Aalborg University, Aalborg; Peter de Nully Brown, Copenhagen University Hospital, Copenhagen; Henrik Frederiksen, Odense University Hospital, Odense; Judit Jørgensen, Aarhus University Hospital, Aarhus; Denmark; Sandra Eloranta and Karin E. Smedby, Karolinska Institutet, Stockholm; Mats Jerkeman, Lund University, Lund; and Karin E. Smedby, Karolinska University Hospital, Solna, Sweden.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/CCI.18.00025
Publisher Site
http://dx.doi.org/10.1200/CCI.18.00025DOI Listing
December 2018

Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma.

Am J Hematol 2018 May 17. Epub 2018 May 17.

Division of Clinical Epidemiology, Department of Medicin Solna, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25147DOI Listing
May 2018

Impact of comorbidity on survival in peripheral T-cell lymphomas: A Swedish Lymphoma Registry study.

Hematol Oncol 2018 Feb 5;36(1):159-165. Epub 2017 May 5.

Department of Clinical Sciences Lund, Section for oncology and pathology, Lund University, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2428DOI Listing
February 2018

International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell Lymphoma.

J Clin Oncol 2017 Dec 26;35(36):4019-4026. Epub 2017 Oct 26.

Matthew J. Maurer, N. Nora Bennani, Stephen M. Ansell, James R. Cerhan, and Andrew L. Feldman, Mayo Clinic, Rochester, MN; Fredrik Ellin, Kalmar County Hospital, Kalmar; Fredrik Ellin and Thomas Relander, Lund University; Mats Jerkeman and Thomas Relander, Skåne University Hospital, Lund; Karin E. Smedby, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden; Line Srour, Joseph M. Connors, Graham W. Slack, and Kerry J. Savage, Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, British Columbia, Canada; and Brian K. Link, University of Iowa Hospitals and Clinics, Iowa City, IA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.8195DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736237PMC
December 2017

The addition of etoposide to CHOP is associated with improved outcome in ALK+ adult anaplastic large cell lymphoma: A Nordic Lymphoma Group study.

Br J Haematol 2017 09 8;178(5):739-746. Epub 2017 May 8.

Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.14740
Publisher Site
http://dx.doi.org/10.1111/bjh.14740DOI Listing
September 2017

Frequency and clinical implications of SOX11 expression in Burkitt lymphoma.

Leuk Lymphoma 2017 07 21;58(7):1760-1763. Epub 2016 Nov 21.

b Department of Immunotechnology , CREATE Health, Lund University , Lund , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1258701DOI Listing
July 2017

Impact on survival of addition of etoposide to primary chemotherapy in diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study.

Hematol Oncol 2017 Jun 15;35(2):151-157. Epub 2015 Sep 15.

Lund University, Department of Clinical Sciences Lund, Department of Oncology, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2256DOI Listing
June 2017

Long-term remission in idiopathic Castleman's disease with tocilizumab followed by consolidation with high-dose melphalan--two case studies.

Eur J Haematol 2016 May 25;96(5):541-3. Epub 2015 Aug 25.

Department of Oncology, Skane University Hospital, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12646DOI Listing
May 2016

Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics.

Am J Hematol 2015 Dec 6;90(12):1128-34. Epub 2015 Oct 6.

Department of Medicine, Clinical Epidemiology Unit, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24184DOI Listing
December 2015

Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study.

J Clin Oncol 2015 Dec 5;33(34):3993-8. Epub 2015 Oct 5.

Tarec Christoffer El-Galaly, Hans Erik Johnsen, and Martin Bøgsted, Aalborg University Hospital; Tarec Christoffer El-Galaly, Lasse Hjort Jakobsen, Hans Erik Johnsen, and Martin Bøgsted, Aalborg University, Aalborg; Martin Hutchings and Peter de Nully Brown, Rigshospitalet, Copenhagen University Hospital, Copenhagen; Karen Juul Mylam, Odense University Hospital, Odense, Denmark; Herman Nilsson-Ehle, Sahlgrenska University Hospital, Gothenburg; Elisabeth Székely and Mats Jerkeman, Lund University Hospital, Lund; and Viktoria Hjalmar, Karolinska Institutet, Stockholm University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.0229DOI Listing
December 2015

Sick leave and disability pension among Swedish testicular cancer survivors according to clinical stage and treatment.

Acta Oncol 2015 Nov 2;54(10):1770-80. Epub 2015 Apr 2.

e Department of Medicine , Karolinska Institutet, Clinical Epidemiology Unit , Stockholm , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2015.1020967DOI Listing
November 2015

Central nervous system relapse in peripheral T-cell lymphomas: a Swedish Lymphoma Registry study.

Blood 2015 Jul 8;126(1):36-41. Epub 2015 May 8.

Department of Oncology, Skane University Hospital, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-12-616961DOI Listing
July 2015

The impact of age on survival of diffuse large B-cell lymphoma - a population-based study.

Acta Oncol 2015 Jun 18;54(6):916-23. Epub 2014 Dec 18.

Department of Radiology, Oncology, and Radiation Sciences, Uppsala University , Uppsala , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2014.978367DOI Listing
June 2015

Male gender is an adverse risk factor only in young patients with diffuse large B-cell lymphoma - a Swedish population-based study.

Acta Oncol 2015 Jun 6;54(6):924-32. Epub 2015 Apr 6.

Department of Radiology, Oncology, and Radiation Sciences, Uppsala University , Uppsala , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2015.1026455DOI Listing
June 2015

Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry.

Blood 2014 Sep 8;124(10):1570-7. Epub 2014 Jul 8.

Department of Oncology, Skane University Hospital, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-04-573089DOI Listing
September 2014

Treatment outcome in T-cell lymphoblastic lymphoma in adults - a population-based study from the Swedish Lymphoma Registry.

Acta Oncol 2014 Jul 10;53(7):927-34. Epub 2014 Mar 10.

Department of Internal Medicine, Kalmar County Hospital , Kalmar , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2014.889850DOI Listing
July 2014

Identification of B-cell lymphoma subsets by plasma protein profiling using recombinant antibody microarrays.

Leuk Res 2014 Jun 22;38(6):682-90. Epub 2014 Mar 22.

Department of Immunotechnology, Lund University, Lund, Sweden; CREATE Health, Lund University, Lund, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2014.03.010DOI Listing
June 2014

High dose cytarabine with rituximab is not enough in first-line treatment of mantle cell lymphoma with high proliferation: early closure of the Nordic Lymphoma Group Mantle Cell Lymphoma 5 trial.

Leuk Lymphoma 2014 May 28;55(5):1206-8. Epub 2013 Aug 28.

Department of Radiology, Oncology and Radiation Science, Uppsala University , Uppsala , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.825906DOI Listing
May 2014

Gene expression profiling indicates that immunohistochemical expression of CD40 is a marker of an inflammatory reaction in the tumor stroma of diffuse large B-cell lymphoma.

Leuk Lymphoma 2012 Sep 16;53(9):1764-8. Epub 2012 Mar 16.

Department of Oncology, Institution of Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3109/10428194.2012.66
Publisher Site
http://dx.doi.org/10.3109/10428194.2012.666541DOI Listing
September 2012

Expanded clinical and experimental use of SOX11 - using a monoclonal antibody.

BMC Cancer 2012 Jun 27;12:269. Epub 2012 Jun 27.

Department of Immunotechnology, Lund University, BMCD13, Lund, SE-221 84, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-12-269DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495897PMC
June 2012

Population based study of prognostic factors and treatment in adult Burkitt lymphoma: a Swedish Lymphoma Registry study.

Leuk Lymphoma 2011 Nov 30;52(11):2090-6. Epub 2011 Jun 30.

Department of Oncology, Skane University Hospital, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2011.593274DOI Listing
November 2011

Marked improvement of overall survival in mantle cell lymphoma: a population based study from the Swedish Lymphoma Registry.

Leuk Lymphoma 2011 Oct 24;52(10):1929-35. Epub 2011 Jun 24.

Department of Oncology, Skane University Hospital, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2011.587560DOI Listing
October 2011

Inhibition of geranylgeranylation mediates sensitivity to CHOP-induced cell death of DLBCL cell lines.

Exp Cell Res 2011 May 13;317(8):1179-91. Epub 2011 Feb 13.

Division of Hematology and Transfusion Medicine, Lund University, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2011.02.006DOI Listing
May 2011

Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy.

Eur J Haematol 2011 Feb 22;86(2):124-8. Epub 2010 Dec 22.

Department of Oncology, Helsinki University Central Hospital, Helsinki Genome-Scale Biology Research Program, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2010.01541.xDOI Listing
February 2011

CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

Leuk Lymphoma 2010 Sep;51(9):1643-8

Department of Oncology, Institution of Clinical Sciences, Lund University and Lund University Hospital, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2010.492537DOI Listing
September 2010

Prognostic impact of protein kinase C beta II expression in R-CHOP-treated diffuse large B-cell lymphoma patients.

Mod Pathol 2010 May 26;23(5):686-93. Epub 2010 Feb 26.

Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2010.43DOI Listing
May 2010

Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP.

Mod Pathol 2009 Aug 15;22(8):1094-101. Epub 2009 May 15.

Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2009.73DOI Listing
August 2009

Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.

Eur J Haematol 2009 May 9;82(5):364-72. Epub 2009 Jan 9.

Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2009.01222.xDOI Listing
May 2009

B cell lymphomas express CX3CR1 a non-B cell lineage adhesion molecule.

Cancer Lett 2008 Feb 3;259(2):138-45. Epub 2007 Dec 3.

Department of Immunotechnology, Lund University, CREATE Health, Lund University, BMC D13, 221 84, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2007.10.031DOI Listing
February 2008

Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma.

Blood 2008 Jan 12;111(2):800-5. Epub 2007 Oct 12.

Department of Immunotechnology, CREATE Health, BioMedical Center, Lund University, and Department of Pathology, Lund University Hospital, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-06-093401DOI Listing
January 2008

CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma.

Leuk Lymphoma 2007 Sep;48(9):1774-9

Department of Oncology, Institution of Clinical Sciences, Lund University Hospital, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190701494520DOI Listing
September 2007

Biphenotypic bigenotypic lymphoma with simultaneous expression of PAX5/BSAP and B- and T-cell markers.

Eur J Haematol 2007 Aug;79(2):159-65

Department of Hematology, Lund University Hospital, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2007.00882.xDOI Listing
August 2007

High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma.

Blood 2005 Apr 2;105(7):2908-15. Epub 2004 Dec 2.

Department of Molecular Medicine, Division of Hematology, Karolinska University Hospital and Karolinska Institutet, SE-171 76 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2004-07-2721DOI Listing
April 2005